Brief: Henlius Says It Entered Strategic Collaboration With Al-Tiryaq Al-Khalawi Medical Company
08/11/2024 16:42
Nov 8 (Reuters) - Shanghai Henlius Biotech Inc
2696.HK :
* HENLIUS: ON MORNING OF NOV 7, ENTERED INTO A STRATEGIC
COLLABORATION WITH AL-TIRYAQ AL-KHALAWI MEDICAL COMPANY
* HENLIUS: CO AND SVAX FORGE STRATEGIC PARTNERSHIP IN MENAT
MARKET, WILL ESTABLISH JOINT VENTURES IN SAUDI ARABIA
Source text: ID:nPn611P68a
Further company coverage: 2696.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Shanghai Henlius Biotech
See all newsBrief: Shanghai Henlius Biotech Says Wenjie Zhang Resigns As Chairman
Brief: Shanghai Henlius Biotech Enters Collaboration And License Agreement With Amberstone Biosciences
Brief: Shanghai Henlius Biotech Says NDA For 120 Mg Biosimilar Denosumab HLX14 Accepted By NMPA
China's Henlius H1 revenue jumps on drug sales, license income
Brief: Shanghai Henlius Biotech Logs HY Profit RMB 430.4 Mln